Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
422.40Today’s High
436.9052W low
330.8052W High
535.90Open Price
436.10Prev. Close
364.0000Volume
230015.00Value
97756375.00Fundamentals
Market Cap Cr
2495.00
Price to Earnings
18.60
Price to Book Value
1.50
Dividend Yield
1.20
PE to Growth
-5.50
Op Revenue TTM Cr
2132.79
Net Profit TTM Cr
134.43
Cash From Operating Activity Cr
290.08
Return on Equity %
8.34
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
41.1
Week
25.5
Month
33.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
434.27
PIVOT
First Resistance
440.68
Second Resistance
447.82
Third Resistance
454.23
First Support
427.13
Second Support
420.72
Third Support
413.58
Relative Strength Index
69.75
Money Flow Index
85.91
MACD
11.77
MACD Signal
9.2
Average True Range
14.33
Average Directional Index
25.03
Rate of Change (21)
20.31
Rate of Change (125)
-8.42
Commodity Channel Index
129.3
Williams %R
-24.9
BETA
1 Month
0.85
3 Month
0.86
1 Year
0.67
3 Year
0.49
PRICE CHANGE ANALYSIS
↑ 5.09%
1 Week
Low
High
401.1
448.9
↑ 17.94%
1 Month
Low
High
330.85
448.9
↑ 9.82%
3 Months
Low
High
330.85
448.9
↓ -11.49%
6 Months
Low
High
330.85
487.95
↑ 4.73%
1 Year
Low
High
330.85
535.9
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 511.44 | 528.77 | 552.41 | 570.24 | 595.93 | 530.12 | 546.47 | 570.16 | 579.42 | 564.02 | 548.39 | |
| Operating Expenses Qtr | 453.84 | 475.91 | 481.20 | 490.32 | 491.42 | 480.44 | 509.74 | 508.99 | 529.37 | 495.93 | 494.08 | |
| Operating Profit Qtr | 50.08 | 44.48 | 64.10 | 72.86 | 95.79 | 43.04 | 31.67 | 56.02 | 43.12 | 59.21 | 43.80 | |
| EBIDT Qtr Cr | 57.60 | 52.86 | 71.21 | 79.92 | 104.51 | 49.68 | 36.73 | 61.17 | 50.05 | 68.09 | 54.31 | |
| Depreciation Qtr | 16.42 | 16.32 | 15.67 | 14.44 | 12.10 | 11.73 | 11.32 | 10.98 | 11.01 | 11.13 | 10.80 | |
| Net Profit Qtr | 28.19 | 23.23 | 37.79 | 46.21 | 65.27 | 24.15 | 15.67 | 34.89 | 27.75 | 40.07 | 30.84 | |
| Basic EPS Qtr | 4.80 | 3.96 | 6.44 | 7.87 | 11.11 | 4.12 | 2.67 | 5.94 | 4.73 | 6.82 | 5.26 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2162.86 | 2242.68 | 2216.06 | 1991.28 | 1910.49 | |
| Operating Expenses Annual Cr | 1901.27 | 1990.59 | 1927.74 | 1375.14 | 1320.59 | |
| Operating Profit Annual | 231.52 | 226.52 | 256.28 | 591.84 | 573.88 | |
| Operating Profit Margin Annual % | 10.70 | 10.10 | 11.56 | 29.72 | 30.04 | |
| Total Expenses Annual Cr | 1980.22 | 2053.19 | 1979.29 | 1419.89 | 1377.25 | |
| EBIDT Annual Cr | 261.59 | 252.09 | 288.32 | 616.14 | 589.90 | |
| EBIDT Annual margin % | 12.09 | 11.24 | 13.01 | 30.94 | 30.88 | |
| Depreciation | 62.85 | 46.13 | 43.26 | 38.92 | 35.73 | |
| PAT Before ExtraOrdinary Items Annual Cr | 135.42 | 139.98 | 165.66 | 444.56 | 361.29 | |
| Net Profit Annual | 135.42 | 139.98 | 165.66 | 444.56 | 361.29 | |
| Basic EPS Annual | 23.07 | 23.84 | 28.22 | 76.21 | 63.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1611.33 | 1506.55 | 1390.27 | 1260.43 | 813.54 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 72.89 | 58.15 | 56.62 | 59.11 | 79.73 | |
| Total Current Liabilities Annual Cr | 559.75 | 455.91 | 513.40 | 290.55 | 282.29 | |
| Total Capital Plus Liabilities Annual Cr | 2243.97 | 2020.61 | 1960.29 | 1610.09 | 1175.56 | |
| Fixed Assets Annual | 1051.27 | 840.95 | 665.84 | 560.63 | 488.23 | |
| Total Non Current Assets Annual | 1124.49 | 1101.54 | 881.58 | 587.80 | 504.62 | |
| Total Current Assets Annual | 1119.48 | 919.07 | 1078.71 | 1022.29 | 670.94 | |
| Total Assets Annual | 2243.97 | 2020.61 | 1960.29 | 1610.09 | 1175.56 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 66.41 | 100.21 | 72.48 | 49.95 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 290.76 | 123.14 | 91.04 | 379.78 | 471.09 | |
| Cash from Investing Activity Annual | -191.69 | -119.19 | -120.29 | -317.25 | -184.52 | |
| Cash from Financing Annual Activity | -92.50 | -4.11 | -1.64 | -58.28 | -271.89 | |
| Net Cash Flow Annual | - | -0.16 | -30.89 | 4.25 | 14.68 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 274.45 | 256.61 | 236.80 | 214.69 | 143.00 | |
| ROE Annual % | 8.40 | 9.29 | 11.91 | 35.27 | 44.40 | |
| ROCE Annual % | 11.80 | 13.16 | 16.93 | 43.74 | 62.03 | |
| Total Debt to Total Equity Annual | 0.02 | 0.05 | 0.03 | 0.00 | 0.07 | |
| EBDIT Annual Margin % | 12.26 | 11.37 | 13.20 | 31.32 | 31.13 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 511.44 | 528.77 | 552.41 | 570.24 | 595.94 | 530.13 | 546.48 | 570.17 | 579.42 | |
| Operating Expenses Qtr | 454.40 | 476.04 | 481.10 | 490.66 | 491.91 | 480.79 | 509.51 | 509.22 | 527.36 | |
| Operating Profit Qtr | 49.52 | 44.35 | 64.20 | 72.52 | 95.30 | 42.69 | 31.90 | 55.79 | 45.13 | |
| EBIDT Qtr Cr | 57.04 | 52.73 | 71.31 | 79.58 | 104.03 | 49.34 | 36.97 | 60.95 | 52.06 | |
| Depreciation Qtr | 16.43 | 16.34 | 15.69 | 14.45 | 12.11 | 11.75 | 11.32 | 10.98 | 11.01 | |
| Net Profit Qtr | 27.62 | 23.08 | 37.87 | 45.86 | 64.78 | 23.79 | 15.91 | 34.67 | 29.76 | |
| Basic EPS Qtr | 4.71 | 3.93 | 6.45 | 7.81 | 11.03 | 4.05 | 2.71 | 5.91 | 5.07 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total Revenue Annual | 2162.86 | 2242.72 | 2216.06 | |
| Operating Expenses Annual Cr | 1902.20 | 1991.44 | 1925.73 | |
| Operating Profit Annual | 230.59 | 225.67 | 258.29 | |
| Operating Profit Margin Annual % | 10.66 | 10.06 | 11.66 | |
| Total Expenses Annual Cr | 1981.21 | 2054.07 | 1977.28 | |
| EBIDT Annual Cr | 260.66 | 251.28 | 290.33 | |
| EBIDT Annual margin % | 12.05 | 11.20 | 13.10 | |
| Depreciation | 62.91 | 46.16 | 43.26 | |
| PAT Before ExtraOrdinary Items Annual Cr | 134.43 | 139.14 | 167.67 | |
| Net Profit Annual | 134.43 | 139.14 | 167.67 | |
| Basic EPS Annual | 22.90 | 23.70 | 28.56 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1611.51 | 1507.72 | 1392.28 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 72.89 | 58.15 | 56.62 | |
| Total Current Liabilities Annual Cr | 560.00 | 456.26 | 513.40 | |
| Total Capital Plus Liabilities Annual Cr | 2244.40 | 2022.13 | 1962.30 | |
| Fixed Assets Annual | 1051.41 | 841.45 | 665.84 | |
| Total Non Current Assets Annual | 1124.63 | 1101.74 | 881.48 | |
| Total Current Assets Annual | 1119.77 | 920.39 | 1080.82 | |
| Total Assets Annual | 2244.40 | 2022.13 | 1962.30 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 66.38 | 100.21 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Cash from Operating Activity Annual | 290.08 | 122.27 | 93.05 | |
| Cash from Investing Activity Annual | -191.28 | -120.00 | -120.19 | |
| Cash from Financing Annual Activity | -92.50 | -4.11 | -1.64 | |
| Net Cash Flow Annual | - | -1.84 | -28.78 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Graph |
|---|---|---|---|---|
| Book Value Per Share Annual | 274.49 | 256.81 | 237.15 | |
| ROE Annual % | 8.34 | 9.22 | 12.04 | |
| ROCE Annual % | 11.74 | 13.09 | 17.05 | |
| Total Debt to Total Equity Annual | 0.02 | 0.05 | 0.03 | |
| EBDIT Annual Margin % | 12.22 | 11.33 | 13.29 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| MAYA DEVI POLYCOT LIMITED | 21.54 | 74213935 | 0 | 0 |
| NCVI ENTERPRISES LIMITED | 15.96 | 74213936 | 0 | 0 |
| NM MERCHANTILES PVT LIMITED | 8.65 | 74213937 | 0 | 0 |
| VARINDER GUPTA | 2.04 | 74213938 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 1.24 | 74213946 |
| VASUDEVA COMMERCIALS LIMITED | 7.94 | 74213951 |
| ENORG LIMITED | 4.43 | 74213952 |
| G CONSULTANTS AND FABRICATORS PVT LTD | 1.68 | 74213953 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 16, 2024 | 5 | INTERIM | Feb 16, 2024 | Equity Share |
| Feb 17, 2023 | 4 | INTERIM | Feb 17, 2023 | Equity Share |
| Feb 15, 2022 | 4 | INTERIM | Feb 16, 2022 | Equity Share |
| Sep 08, 2021 | 2 | FINAL | - | Equity Share |
| Nov 17, 2020 | 4 | INTERIM | Nov 18, 2020 | Equity Share |
| Mar 18, 2020 | 3 | INTERIM | Mar 19, 2020 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 14, 2024 | Audited Results | - |
| Feb 06, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 09, 2023 | Quarterly Results | - |
| Apr 28, 2023 | Audited Results | - |
| Feb 07, 2023 | Audited Results & Interim Dividend | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 30, 2022 | Quarterly Results | - |
| Feb 04, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 04, 2021 | Audited Results | - |
| Feb 10, 2021 | Quarterly Results | - |
| Nov 06, 2020 | Quarterly Results & Interim Dividend | - |
| Jul 31, 2020 | Quarterly Results | - |
| Jun 12, 2020 | Audited Results | - |
| Mar 11, 2020 | Interim Dividend | - |
| Feb 10, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 29, 2019 | Audited Results | - |
| Feb 12, 2019 | Quarterly Results & Preferential issue | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 11, 2018 | Quarterly Results | - |
| May 16, 2018 | Audited Results | - |
| Feb 12, 2018 | Quarterly Results | - |
| Nov 13, 2017 | Quarterly Results | - |
| Aug 18, 2017 | Quarterly Results | - |
| May 27, 2017 | Audited Results | - |
| Feb 11, 2017 | Quarterly Results | - |
| Nov 07, 2016 | Quarterly Results | - |
| Aug 08, 2016 | Quarterly Results | - |
| May 02, 2016 | Audited Results | - |
| Jan 30, 2016 | Quarterly Results & Others | Re-appointment of Mr. Vijay Kumar Garg as Joint Managing Director of the Company for three year w.e.f. March 02, 2016. |
| Nov 27, 2015 | Allotted Equity Shares | Allotted 7,25,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014. |
| Oct 31, 2015 | Quarterly Results | - |
| Aug 13, 2015 | Quarterly Results | Appointment of Mr. Pardeep Khanna as Chief Financial Officer (CFO) of the Company in place of Mr. Rakesh Mahajan. |
| May 29, 2015 | Audited Results | Appointment of Mr. Vikas Gupta as Additional and Executive Director of the Company. |
| Feb 13, 2015 | Quarterly Results | - |
| Nov 28, 2014 | Quarterly Results & Others | To consider and approve the Conversion of FCCBs into equity shares, un-audited financial results of the Company for the quarter and half year ended |
| Oct 29, 2014 | Others | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 21, 2014 | Increase in Authorised Capital | 1. Increase in the Authorised Share Capital of the Co. from Rs 54 crores to Rs 80 crores. 2. Issue of upto 5000000 equity shares of face value Rs. 10 each & Issue of upto 11000,000 equity Warrants. |
| Feb 08, 2014 | Quarterly Results | - |
| Nov 09, 2013 | Quarterly Results | - |
| Aug 12, 2013 | Quarterly Results | - |
| May 27, 2013 | Audited Results | - |
| Feb 14, 2013 | Quarterly Results | - |
| Nov 10, 2012 | Quarterly Results | - |
| Aug 14, 2012 | Quarterly Results | - |
| May 30, 2012 | Audited Results | - |
| Mar 31, 2012 | Resignation / Appointment of Director's | The Board has accepted the resignation of Sh. Kanwal Pushkarnath Pandita & Smt. Dimple Gupta from Directionship of the Co. & Appointed of Sh. Narender Kumar Pundir as Additional Director & Director. |
| Feb 11, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 12, 2011 | Quarterly Results | - |
| May 21, 2011 | Audited Results | - |
| Feb 08, 2011 | Quarterly Results | (Revised) |
| Nov 13, 2010 | Quarterly Results | - |
| Aug 27, 2010 | Others | The Board has exercised its over allotment option with respect to an additional USD 2 million Zero Coupon FCCBs out of the over allotment option of USD 10 million & allotted FCCB of USD 2 million. |
| Aug 11, 2010 | Quarterly Results | - |
| Jul 17, 2010 | To issue of Equity Warrants | To issue of 15,00,000 Equity Warrants, carrying an option to the holder of such Warrants to subscribe to 1 Equity Share of Rs. 10/- for every Warrant held, within 18 months from the date of allotment. |
| May 29, 2010 | Audited Results & Others | The Board has approved CAPAX of Rs. 130 Crs for capacity enhancement and diversification for more pharmaceuticals product. |
| May 15, 2010 | Increase in Authorised Capital & Others | To increase in Authorized Share Capital from Rs. 35 Cr to Rs. 45 Cr & to issue of US$ 5 million, Zero Coupon Unsecured FCCBs (subject to an Option to issue an additional US$10 million of such bonds). |
| Jan 30, 2010 | Quarterly Results | - |
| Dec 10, 2009 | Increase in Authorised Capital & Others | To increase the Authorised Share Capital of the Company from Rs. 30 Crs to Rs. 35 Crs, to issue of 15,00,000 Equity Shares and 30,00,000 Equity Warrants & to call an EGM of the Co. on Jan 09, 2010. |
| Oct 31, 2009 | Quarterly Results | - |
| Jul 31, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results | - |
| Jan 23, 2009 | Quarterly Results | - |
| Oct 31, 2008 | Quarterly Results | - |
| Jul 31, 2008 | Quarterly Results | - |
| May 05, 2008 | Audited Results | - |
| Jan 30, 2008 | Quarterly Results | - |
| Oct 15, 2007 | Quarterly Results | - |
| Sep 25, 2007 | To consider the issue of securities | inter alia, to consider the issue of securities to Indiastar (Mauritius) Ltd and / or to the promoters on preferential basis. |
| Jul 30, 2007 | Quarterly Results | - |
| Jun 23, 2007 | Increase in Authorised Capital | - |
| Feb 14, 2007 | Allotment of equity shares | To allot 14,00,000 equity shares of Rs 10/- each for cash at a premium of Rs 45/- per share against the outstanding warrants issued on February 09, 2006. |
| Jan 31, 2007 | Quarterly Results | - |
| Oct 31, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results | - |
| May 06, 2006 | Accounts | - |
| Mar 13, 2006 | To approve the Draft Prospectus | To approve the Draft Red Herring Prospectus for the Follow on Public Issue of the Company aggregating Rs 300 million. |
| Jan 14, 2006 | Quarterly Results | - |
| Dec 01, 2005 | Preferential allotment of warrants | - |
| Oct 27, 2005 | Quarterly Results | - |
| Aug 20, 2005 | Rights & Pref. Issue of Equity Shares | - |
| Jul 13, 2005 | Quarterly Results | - |
| Apr 30, 2005 | Accounts | - |
| Jan 22, 2005 | Quarterly Results | - |
| Oct 30, 2004 | Quarterly Results | - |
| Jul 31, 2004 | Quarterly Results | - |
| Apr 17, 2004 | Accounts | - |
| Mar 20, 2004 | Preferential Issue of shares | - |
| Jan 28, 2004 | Quarterly Results | - |
| Oct 21, 2003 | Quarterly Results | (Revised) |
| Jul 26, 2003 | Quarterly Results | - |
| Jun 28, 2003 | Accounts | - |
| Jan 18, 2003 | Quarterly Results | - |
| Oct 31, 2002 | Quarterly Results | (Revised) |
| Aug 31, 2002 | Quarterly Results | - |
| Jul 31, 2002 | Quarterly Results | - |
| Jun 05, 2002 | Accounts | - |
| Mar 27, 2002 | Accounts & Quarterly Results | - |
| Oct 27, 2001 | Quarterly Results | - |
| Aug 31, 2001 | Quarterly Results | - |
| Apr 28, 2001 | Quarterly Results | - |
| Mar 14, 2001 | Quarterly Results & Accounts | - |
| Oct 30, 2000 | Quarterly Results | - |
| Jul 27, 2000 | Quarterly Results | - |
| Apr 28, 2000 | Quarterly Results | - |
| Mar 16, 2000 | Accounts | - |
| Oct 30, 1999 | Quarterly Results | - |
| Jul 28, 1999 | Quarterly Results | - |
| Apr 27, 1999 | Quarterly Results | - |
| Feb 27, 1999 | Accounts & Quarterly Results | - |
| Feb 25, 1999 | Accounts & Quarterly Results | - |
| Oct 27, 1998 | Quarterly Results | - |
| Jul 30, 1998 | Quarterly Results | - |
| Mar 06, 1998 | Accounts | - |
| Aug 30, 1997 | Half Yearly Results. | - |
| Jan 31, 1997 | Accounts. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
IOLCP's stock rallies 10% after securing nod for cholesterol drug
The stock price jump came after the company got China's drug regulatory authority NMPA's nod for cholesterol drug Fenofibrate, allowing the company to export it to the Chinese market
01 Jul 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - National Medical Products Administration (NMPA), China Approves Fenofibrate Manufactured By The Company
NMPA, China approves Fenofibrate manufactured by the Company
26 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmed of Credit Rating for bank facilities
26 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window
Notice of closure of Trading Window
18 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates
15 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Schedule Of Analyst /Institutional Investor Meeting
Schedule of analyst/institutional meeting
14 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Issue of Letter of Confirmation in lieu of lost share certificate
12 Jun 2024
IOL Chemicals share price up 6% on bagging CEP certificate for Pantoprazole
Pantoprazole is used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD)
11 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Company Received CEP Certificate For 'Allopurinol'
Company received CEP Certificate for "Allopurinol"
11 Jun 2024
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Company Received CEP Certificate For 'Pantoprazole Sodium Sesquihydrate' For Alternative Process (Process - II)
Company received CEP Certificate for "Pantoprazole Sodium Sesquihydrate" for alternative process (Process - II)
